ImmuCell reports 18% sales growth in Q2 2025
Go back to ImmuCell reports 18% sales growth in Q2 2025| Immucell Corp (NASDAQ: ICCC) | Delayed: 10.06 -0.03 (0.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.09 | 52 Week High | $8.29 | |||
| Open | $10.09 | 52 Week Low | $4.99 | |||
| Day High | $10.49 | P/E | 125.75 | |||
| Day Low | $10.05 | EPS | $0.08 | |||
| Volume | 11,131 | |||||

